These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 82581)

  • 1. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
    Haughton G; Lanier LL; Babcock GF; Lynes MA
    J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
    Arnold LW; LoCascio NJ; Lutz PM; Pennell CA; Klapper D; Haughton G
    J Immunol; 1983 Oct; 131(4):2064-8. PubMed ID: 6194226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2.
    Lynes MA; Lanier LL; Babcock GF; Wettstein PJ; Haughton G
    J Immunol; 1978 Dec; 121(6):2352-7. PubMed ID: 363945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen receptors on murine T lymphocytes in contact sensitivity. II. Presentation and characterization of syngeneic anti-idiotype serum against DNFB-sensitized T cells.
    Moorhead JW; Sy MS
    J Immunol; 1982 Jun; 128(6):2533-8. PubMed ID: 6176644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of a murine B lymphoma tumor-specific antigen.
    Koch S; Zalcberg JR; McKenzie IF
    J Immunol; 1984 Aug; 133(2):1070-7. PubMed ID: 6203965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.
    Bankert RB; Yokota S; Ghosh SK; Mayhew E; Jou YH
    Cancer Res; 1989 Jan; 49(2):301-8. PubMed ID: 2783380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
    Hatzubai A; Maloney DG; Levy R
    J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.